AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1

Metwalk G 1mg/500mg Tablet SR

Prescription Icon
Prescription Required

Marketer

Enegix Healthcare

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Metwalk G 1mg/500mg Tablet SR

Glimepiride/Metformin 1mg/500mg extended-release tablets are antidiabetic medications, combining two drugs to manage type 2 diabetes in adults. These tablets help regulate blood glucose. Administer this medication with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on blood sugar monitoring. Continue taking this medicine as prescribed, even if feeling well or experiencing controlled blood sugar, as abrupt cessation can elevate glucose levels, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. This medication is part of a comprehensive diabetes management plan incorporating diet, exercise, and weight management as advised by your doctor. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is a common side effect; learn to recognize symptoms like sweating, dizziness, headache, and tremors, and know how to treat them. Maintain regular meals and carry a readily available fast-acting glucose source. Alcohol consumption should be limited due to increased hypoglycemia risk. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain may occur. Avoid use if you have type 1 diabetes, diabetic ketoacidosis, or severe kidney or liver impairment. Inform your doctor about any history of heart disease before starting this medication; it may not be appropriate. Pregnant or breastfeeding individuals should consult their physician prior to use. Regular blood glucose monitoring, along with potential blood tests to track blood cell counts and liver function, are recommended.

Primary Ingredients of Metwalk G 1mg/500mg Tablet SR

No text provided to rephrase.

Uses of Metwalk G 1mg/500mg Tablet SR

Managing type 2 diabetes

Major Benefits of Metwalk G 1mg/500mg Tablet SR:

Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment schedule. Ingest the entire tablet; avoid chewing, crushing, or fracturing it. Consume Metwalk G 1mg/500mg Extended-Release Tablet with food.

Common Side effects of Metwalk G 1mg/500mg Tablet SR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Metwalk G 1mg/500mg Tablet SR:

Administer this medication precisely as your physician directs, adhering to the prescribed dosage and treatment length. Ingest the Metwalk G 1mg/500mg Tablet SR whole; avoid chewing, crushing, or fracturing it. Consume this medication with food.

How Metwalk G 1mg/500mg Tablet SR works:

Metformin and Glimepiride, combined as Metwalk G 1mg/500mg sustained-release tablets, offer a dual approach to diabetes management. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose uptake, and enhancing insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent use of alcohol and Metwalk G 1mg/500mg SR tablets is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Metwalk G 1mg/500mg SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential advantages against any risks prior to prescribing. Always seek medical advice.

Breast feedingBreast feedingUNSAFE

The extended-release Metwalk G 1mg/500mg tablet is contraindicated during lactation due to potential infant toxicity.

DrivingDrivingCAUTION

Impaired driving is possible with both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.

KidneyKidneyCAUTION

Patients with kidney impairment should use Metwalk G 1mg/500mg SR tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates Metwalk G 1mg/500mg SR tablet use. Physician consultation is essential. Routine kidney function monitoring is advised during treatment.

LiverLiverCAUTION

Exercise caution when prescribing Metwalk G 1mg/500mg Tablet SR to individuals with hepatic impairment; dosage modification may be necessary. Consult a physician. For patients experiencing mild to moderate liver dysfunction, initiate therapy with a reduced Metwalk G 1mg/500mg Tablet SR dosage; avoid use in those with severe liver disease.

What if you forget to take Metwalk G 1mg/500mg Tablet SR :

Should you forget a dose of Metwalk G 1mg/500mg Extended-Release Tablet, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Metwalk G 1mg/500mg Tablet SR

LabelValue
Developing Habits No.
Treatment Category Diabetes Treatment

FAQs on Metwalk G 1mg/500mg Tablet SR

Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication; keep it out of reach of children, pets, and others.
Metwalk G 1mg/500mg Tablet SR can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare but dangerous side effect is more likely in patients with kidney disease, older adults, or those who consume significant amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and slow heart rate. If you experience these, discontinue Metwalk G 1mg/500mg Tablet SR and seek immediate medical attention.
Metwalk G 1mg/500mg SR tablets combine glimepiride and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's not suitable for type 1 diabetes.
Metwalk G 1mg/500mg SR Tablets may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use may also result in vitamin B12 deficiency.
Prolonged use of Metwalk G 1mg/500mg Tablet SR can lead to Vitamin B12 deficiency by hindering its absorption. This deficiency, if left untreated, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, annual supplementation with Vitamin B12 is recommended by some researchers.
Metwalk G 1mg/500mg Tablet SR can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Therefore, regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Metwalk G 1mg/500mg SR tablets with alcohol is unsafe. This combination may cause dangerously low blood sugar (hypoglycemia) and increase the risk of lactic acidosis.
Metwalk G 1mg/500mg Table...
48
MRP 55
12% off